Factors that Influence Fenofibrate Effects on Cancer Cells

Journal Title: Journal of Hematology and Oncology Research - Year 2014, Vol 1, Issue 1

Abstract

No Abstract

Authors and Affiliations

Spiros A. Vlahopoulos

Keywords

Related Articles

The Daughter of Time: Late Development of Waldenstrom’s Macroglobulinemiain a Patient with Immunotactoid Glomerulopathy.

Immunotactoid glomerulopathy (ITG) is a rare cause of chronic kidney disease (CKD) and end-stage-renal-disease (ESRD). It is often associated with monoclonal gammopathy and/or hematologic malignancy. We report a patient...

The Silver, Cobalt, Chromium, Iron, Mercury, Rubidium, Antimony, Selenium, and Zinc Contents in Human Bone Affected by Chondrosarcoma

Objectives: To clarify the role of trace elements in the etiology and the pathogenesis of the chondrosarcoma, a non-destructive neutron activation analysis with high resolution spectrometry of long-lived radionuclides we...

Evaluating the Role and Efficacy of Plerixafor in Rescue Mobilization of Autologous Peripheral Blood Stem Cells

In autologous hematopoietic stem cell transplantation patients for whom granulocyte-colony stimulating factor fails to mobilize a sufficient number of peripheral blood stem cells, plerixafor proposes an option for succes...

Reduced Physical Activity Patterns in Patients with Thalassemia Compared to Healthy Controls

Background: Patients with Thal (Thalassemia) are presumed to be inactive for many of the same reasons as healthy adults, though there are limited published data to support this claim. The primary aim of this study was t...

Early Detection of Post-transplant Lymphoproliferative Disorder by Head and Neck Manifestations

Introduction: Post-transplant lymphoproliferative disease (PTLD) is a collection of conditions associated with abnormal proliferation of lymphoid tissues in patients after solid organ transplants (SOT). Its clinical pre...

Download PDF file
  • EP ID EP249372
  • DOI 10.14302/issn.2372-6601.jhor-13-362
  • Views 195
  • Downloads 0

How To Cite

Spiros A. Vlahopoulos (2014). Factors that Influence Fenofibrate Effects on Cancer Cells. Journal of Hematology and Oncology Research, 1(1), 34-39. https://europub.co.uk/articles/-A-249372